Who Are We?

Vivera is an innovative, science-driven pharmaceutical company focused on novel therapies for a variety of indications. In addition to its pharmaceutical, medical device, advanced diagnostics, medical supply, medical technologies, neurosciences, and health and human service divisions, the Company has global exclusivity to license the patented and patent-pending TABMELT®️ sublingual drug-delivery system for the pharmaceutical use of therapeutic compounds. Vivera is vertically integrated with technology, manufacturing capabilities, and distribution for its products.

We Put Patients First

Vivera is committed to continued research and development of innovative non-addictive pain management products. We believe that now is the time to combat some of the most serious problems affecting patients, physicians, and caregivers, including safe pain management and opiate cessation and deterrence programs. Through its non-profit platform, Vivera Cares, Vivera intends to extend the same mission to its local and global community.

Making A Difference

Vivera is committed to making a positive difference in our local and global communities. Through our non-profit, Vivera Cares, we assist those who need it most. This includes helping underserved communities like Tribal Nations and frontline health care workers access valuable resources like COVID-19 testing and medical supplies.

Press Releases


Innovation is the lifeblood of Vivera. With six divisions, each focused on a specific crisis response, Vivera’s vertically integrated structure has created an agile and responsive model.

Patents, pending and licensed.

Vivera is changing the future of drug delivery across the globe with its intellectual property portfolio.


Vivera is Proudly Partnered With: